The insulin dosage market in South Africa witnessed a fluctuating trend over the past years, with significant year-to-year variations. In 2023, the market size stood at $196.34 million USD, a modest increase of 0.82% from the previous year. The last two years saw growth rates of 0.84% and 0.82% respectively, reflecting moderate but consistent growth. The Compound Annual Growth Rate (CAGR) over the last 5 years is 0.56%, indicating a slow but steady upward trend.
Looking ahead to the forecast period from 2024 to 2028, the projected CAGR is 0.62%, suggesting a continued gradual expansion. The insulin market is expected to grow at an average annual rate of 3.13% during this period.
Future trends to watch for include:
- Innovations in insulin delivery systems.
- Government healthcare initiatives and policies.
- Market penetration of biosimilar insulin products.
